Stockreport

Jazz, Zymeworks' Ziihera trial shows significant PFS improvement, shares rally [Seeking Alpha]

Zymeworks Inc.  (ZYME) 
Last zymeworks inc. earnings: 3/2 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.zymeworks.com/overview
PDF or without Tevimbra, as a first-line treatment for HER2-positive advanced gastroesophageal cancers, sparking a rally in premarket activity. The results were announced [Read more]